Two spine devicemakers are expecting full-year revenue increases, according to unaudited financial results posted Jan. 12.
Carlsmed, which develops aprevo personalized spine implants expects full-year revenue of $50.5 million, an 86% increase compared to 2024. Fourth quarter revenue is expected to reach $15.2 million.
Alphatec expects full-year revenue of $764 million, a 25% increase year over year. The company is also eyeing fourth quarter revenue of $212.2 million to $213.2 million.
